Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma

Hyung Park(New York University), Eva Petkova(Nathan Kline Institute for Psychiatric Research), Dipyaman Ganguly(The University of Texas MD Anderson Cancer Center), Mengling Liu(New York University), Elliott M. Antman(Brigham and Women's Hospital), Leandro Burgos Pratx(Hospital Italiano de Buenos Aires), Katharine J. Bar(University of Pennsylvania), Yogiraj Ray, Ventura Simonovich(Hospital Italiano de Buenos Aires), Artur Belov(Center for Biologics Evaluation and Research), Paula Scibona(Hospital Italiano de Buenos Aires), Priscilla Y. Hsue, C. Avendaño(Hospital Universitario Puerta de Hierro Majadahonda), Geert Meyfroidt(KU Leuven), André Moraes Nicola(Universidade de Brasília), Hyunah Yoon(Albert Einstein College of Medicine), Keith Goldfeld(New York University), Carlos H. Villa(Center for Biologics Evaluation and Research), Danni Wu(New York University), Liise-anne Pirofski(Montefiore Medical Center), Bart Rijnders(Rega Institute for Medical Research), Waldo Belloso(Hospital Italiano de Buenos Aires), Yinxiang Wu(University of Washington), Yin Huang(Center for Biologics Evaluation and Research), Nicole Verdun(Center for Biologics Evaluation and Research), Rafael F. Duarte(Institut Català d'Oncologia), Anne F. Luetkemeyer(University of California, San Francisco), Richard A. Forshee(Center for Biologics Evaluation and Research), Mila B. Ortigoza(New York University), Prasun Bhattacharya(Medical College and Hospital, Kolkata), Thaddeus Tarpey(New York University), Jinchun Zhang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yi Li(University of Electronic Science and Technology of China), Aparna Mukherjee(Indian Council of Medical Research), Andrea B. Troxel, Anup Agarwal(Indian Council of Medical Research), Shekhar Ranjan Paul
JAMA Network Open
January 25, 2022
Cited by 66


Related Papers